MX2012008989A - Metodos de sintetizacion y aislamiento de n-(bromoacetil)-3,3-dini troazetidina y composicion que incluye la misma. - Google Patents

Metodos de sintetizacion y aislamiento de n-(bromoacetil)-3,3-dini troazetidina y composicion que incluye la misma.

Info

Publication number
MX2012008989A
MX2012008989A MX2012008989A MX2012008989A MX2012008989A MX 2012008989 A MX2012008989 A MX 2012008989A MX 2012008989 A MX2012008989 A MX 2012008989A MX 2012008989 A MX2012008989 A MX 2012008989A MX 2012008989 A MX2012008989 A MX 2012008989A
Authority
MX
Mexico
Prior art keywords
abdnaz
bromoacetyl
synthesizing
isolating
dnaz
Prior art date
Application number
MX2012008989A
Other languages
English (en)
Spanish (es)
Inventor
Nicholas A Straessler
Louis F Cannizzo
Ping Li
Michael P Kramer
David M Rosenberg
Original Assignee
Alliant Techsystems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alliant Techsystems Inc filed Critical Alliant Techsystems Inc
Publication of MX2012008989A publication Critical patent/MX2012008989A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
MX2012008989A 2010-02-09 2011-01-18 Metodos de sintetizacion y aislamiento de n-(bromoacetil)-3,3-dini troazetidina y composicion que incluye la misma. MX2012008989A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12/702,782 US8471041B2 (en) 2010-02-09 2010-02-09 Methods of synthesizing and isolating N-(bromoacetyl)-3,3-dinitroazetidine and a composition including the same
PCT/US2011/021500 WO2011100090A1 (en) 2010-02-09 2011-01-18 Methods of synthesizing and isolating n-(bromoacetyl)-3,3-dinitroazetidine and a composition including the same

Publications (1)

Publication Number Publication Date
MX2012008989A true MX2012008989A (es) 2012-08-23

Family

ID=43875262

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012008989A MX2012008989A (es) 2010-02-09 2011-01-18 Metodos de sintetizacion y aislamiento de n-(bromoacetil)-3,3-dini troazetidina y composicion que incluye la misma.

Country Status (12)

Country Link
US (1) US8471041B2 (https=)
EP (1) EP2534131B1 (https=)
JP (1) JP5461712B2 (https=)
KR (1) KR101456438B1 (https=)
CN (1) CN102762535B (https=)
AU (1) AU2011216176B2 (https=)
CA (1) CA2788459C (https=)
DK (1) DK2534131T3 (https=)
ES (1) ES2460040T3 (https=)
IL (1) IL221141A (https=)
MX (1) MX2012008989A (https=)
WO (1) WO2011100090A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070135380A1 (en) 2005-08-12 2007-06-14 Radiorx, Inc. O-nitro compounds, pharmaceutical compositions thereof and uses thereof
US7507842B2 (en) 2005-08-12 2009-03-24 Radiorx, Inc. Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof
US8664247B2 (en) 2011-08-26 2014-03-04 Radiorx, Inc. Acyclic organonitro compounds for use in treating cancer
US20140308260A1 (en) 2011-10-07 2014-10-16 Radiorx, Inc. Methods and compositions comprising a nitrite-reductase promoter for treatment of medical disorders and preservation of blood products
CA2850723C (en) 2011-10-07 2019-07-09 Radiorx, Inc. Organonitro thioether compounds and medical uses thereof
US10342778B1 (en) 2015-10-20 2019-07-09 Epicentrx, Inc. Treatment of brain metastases using organonitro compound combination therapy
US9987270B1 (en) 2015-10-29 2018-06-05 Epicentrix, Inc. Treatment of gliomas using organonitro compound combination therapy
CN109069420A (zh) 2016-01-11 2018-12-21 埃皮辛特瑞柯斯公司 2-溴-1-(3,3-二硝基氮杂环丁烷-1-基)乙酮静脉施用的组合物和方法
SG11201903312VA (en) 2016-10-14 2019-05-30 Epicentrix Inc Sulfoxyalkyl organonitro and related compounds and pharmaceutical compositions for use in medicine
EP3648740A1 (en) 2017-07-07 2020-05-13 EpicentRx, Inc. Compositions for parenteral administration of therapeutic agents
WO2019164593A2 (en) 2018-01-08 2019-08-29 Epicentrx, Inc. Methods and compositions utilizing rrx-001 combination therapy for radioprotection
BR112023025535A2 (pt) 2021-06-09 2024-02-27 Epicentrx Inc Composições de abdnaz cristalinas e métodos para fazer e usar as mesmas
WO2024145484A1 (en) 2022-12-29 2024-07-04 Epicentrx, Inc. Rrx-001 for treating reproductive-related disorders

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4935450A (en) 1982-09-17 1990-06-19 Therapeutical Systems Corporation Cancer therapy system for effecting oncolysis of malignant neoplasms
JPS60116642A (ja) 1983-11-29 1985-06-24 Nippon Kayaku Co Ltd 2−モノ−置換メチル−5,5−ジメチル−シクロ−2−ヘキセノン誘導体
GB8504253D0 (en) 1985-02-19 1985-03-20 Ici Plc Electrostatic spraying apparatus
GB8728418D0 (en) 1987-12-04 1988-01-13 Jenkins T C Nitro-substituted aromatic/hetero-aromatic compounds for use in cancer treatment
DE3815221C2 (de) 1988-05-04 1995-06-29 Gradinger F Hermes Pharma Verwendung einer Retinol- und/oder Retinsäureester enthaltenden pharmazeutischen Zubereitung zur Inhalation zur Einwirkung auf die Schleimhäute des Tracheo-Bronchialtraktes einschließlich der Lungenalveolen
US5693794A (en) 1988-09-30 1997-12-02 The United States Of America As Represented By The Secretary Of The Navy Caged polynitramine compound
JP2659614B2 (ja) 1990-11-13 1997-09-30 株式会社日立製作所 表示制御装置
US5698155A (en) 1991-05-31 1997-12-16 Gs Technologies, Inc. Method for the manufacture of pharmaceutical cellulose capsules
US5336784A (en) 1993-06-07 1994-08-09 The Regents Of The University Of California Synthesis of 1,3,3-trinitroazetidine
JP3211892B2 (ja) 1994-05-27 2001-09-25 セイジィ ファーマスーティカルス インコーポレーテッド 肛門疾患を治療する窒素酸化物供与体及び方法
US5970974A (en) 1995-03-14 1999-10-26 Siemens Aktiengesellschaft Dosating unit for an ultrasonic atomizer device
DE69605025T2 (de) 1995-03-14 2000-07-20 Siemens Ag Ultraschallzerstäuber mit abnehmbarer präzisionsdosiereinheit
WO1996036602A1 (en) 1995-05-15 1996-11-21 The United States Of America Adnaz, compositions and processes
US5580988A (en) 1995-05-15 1996-12-03 The United States Of America As Represented By The Secretary Of The Army Substituted azetidines and processes of using them
US5898038A (en) 1996-03-19 1999-04-27 Board Of Regents, The University Of Texas System Treatment of osteoporosis and metabolic bone disorders with nitric oxide substrate and/or donors
IL128589A0 (en) 1996-10-15 2000-01-31 Eastman Chem Co Explosive formulations
GB9720797D0 (en) 1997-09-30 1997-12-03 Rhodes John Pharmaceutical composition for the treatment of inflammatory bowel disease and irritable bowel syndrome
US5954047A (en) 1997-10-17 1999-09-21 Systemic Pulmonary Development, Ltd. Methods and apparatus for delivering aerosolized medication
US6056966A (en) 1998-05-18 2000-05-02 Baker Norton Pharmaceuticals, Inc. Method and compositions for treating impotence
EP1098641B1 (en) 1998-07-27 2016-04-27 St. Jude Pharmaceuticals, Inc. Chemically induced intracellular hyperthermia
US6448253B1 (en) 1998-09-16 2002-09-10 King Pharmaceuticals Research And Development, Inc. Adenosine A3 receptor modulators
US6245799B1 (en) 1999-11-08 2001-06-12 American Home Products Corp [(Indol-3-yl)-cycloalkyl]-3-substituted azetidines for the treatment of central nervous system disorders
PL358623A1 (en) 2000-04-10 2004-08-09 Pfizer Products Inc. Benzoamide piperidine compounds as substance p antagonists
US6861530B2 (en) 2000-07-07 2005-03-01 Kyowa Hakko Kogyo Co., Ltd. Piperidine derivatives
DE10111049A1 (de) 2001-03-06 2002-09-12 Beiersdorf Ag Verwendung von Substanzen, die verhindern, daß die NO-Synthese des warmblütigen Organismus ihre Wirkung entfaltet, zur Herstellung von kosmetischen oder dermatologischen Zubereitungen, zur Prophylaxe und Behandlung von entzündlichen Hautzuständen und/oder zum Hautschutz bei empfindlich determinierter trockener Haut
EP1336602A1 (en) 2002-02-13 2003-08-20 Giovanni Scaramuzzino Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases
CA2491127A1 (en) 2002-07-03 2004-01-15 Nitromed, Inc. Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
US20040167212A1 (en) 2002-10-07 2004-08-26 Bednarski Mark D. X-nitro compounds, pharmaceutical compositions thereof and uses thereof
US6870061B2 (en) 2003-01-10 2005-03-22 Alliant Techsystems Inc. Continuous process and system for production of glycidyl nitrate from glycerin, nitric acid and caustic and conversion of glycidyl nitrate to poly(glycidyl nitrate)
EP1603933A2 (en) 2003-03-13 2005-12-14 Nitromed, Inc. Nitrosated and nitrosylated compounds, compositions and methods of use
ATE500216T1 (de) 2003-06-25 2011-03-15 Je Il Pharmaceutical Co Ltd Tricyclische derivate oder pharmazeutisch unnbedenkliche salze davon, deren herstellung und pharmazeutische zusammensetzungen, die diese enthalten
GB0326047D0 (en) 2003-11-07 2003-12-10 Univ Sheffield Substance
EP1791544A4 (en) 2004-09-08 2007-09-12 Chelsea Therapeutics Inc CHINAZOLINE DERIVATIVES AS METABOLIC INERT ANTIFOLATE
US7507842B2 (en) * 2005-08-12 2009-03-24 Radiorx, Inc. Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof
US20070135380A1 (en) 2005-08-12 2007-06-14 Radiorx, Inc. O-nitro compounds, pharmaceutical compositions thereof and uses thereof
JP2009510073A (ja) 2005-09-27 2009-03-12 ノバルティス アクチエンゲゼルシャフト カルボキシアミン化合物およびその使用方法
KR100967848B1 (ko) * 2008-05-28 2010-07-05 국방과학연구소 분자화약이 도입된, 고에너지 결합제용1-글리시딜-3,3-디니트로아제티딘 및 그의 제조방법
WO2012078992A1 (en) 2010-12-09 2012-06-14 Radiorx, Inc. Organonitro compounds for use in treating non-hodgkin's lymphoma and leukemia, and methods relating thereto

Also Published As

Publication number Publication date
KR20130053385A (ko) 2013-05-23
CA2788459C (en) 2016-01-05
JP5461712B2 (ja) 2014-04-02
AU2011216176A1 (en) 2012-08-23
EP2534131B1 (en) 2014-03-19
EP2534131A1 (en) 2012-12-19
WO2011100090A1 (en) 2011-08-18
KR101456438B1 (ko) 2014-10-31
ES2460040T3 (es) 2014-05-13
IL221141A0 (en) 2012-09-24
US8471041B2 (en) 2013-06-25
JP2013518925A (ja) 2013-05-23
CA2788459A1 (en) 2011-08-18
DK2534131T3 (da) 2014-04-07
CN102762535A (zh) 2012-10-31
CN102762535B (zh) 2014-09-03
IL221141A (en) 2016-08-31
US20110195947A1 (en) 2011-08-11
AU2011216176B2 (en) 2013-11-14

Similar Documents

Publication Publication Date Title
MX2012008989A (es) Metodos de sintetizacion y aislamiento de n-(bromoacetil)-3,3-dini troazetidina y composicion que incluye la misma.
EA201591671A1 (ru) Аэрированные композиционные материалы, способы их получения и применения
EA201690405A1 (ru) Аэрированные композиционные материалы, способы их получения и применения
MY158251A (en) Method for the preparation of nalmefene hydrochloride
EA201291470A1 (ru) Замороженное кондитерское изделие
PH12012502352A1 (en) Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application
PH12013501678B1 (en) Inkjet treatment liquid and image forming method using treatment liquid
EA200900793A1 (ru) Способ получения эзетимиба и его производных
WO2012082672A3 (en) Process and intermediates for preparing macrolactams
MX2013000773A (es) Procedimiento de preparacion de derivados de amino-benzoil-benzofu rano.
WO2012042534A3 (en) Preparation of r-sitagliptin and intermediates thereof
WO2013002486A3 (ko) 고상 반응에 의한 리튬 망간 산화물의 제조 방법
WO2014176469A3 (en) Improved methods for making ribosomes
WO2009138847A3 (en) An improved process for the preparation of cefozopran
GB2482826A (en) Synthesis of morphine and related derivatives
MX356476B (es) Métodos para aislar 4-cloro-2-fluor-3-fenil boronatos sustituidos y métodos para su uso.
WO2014115174A8 (en) Novel approach for synthesis of catechins
WO2012050315A3 (ko) Fp-cit 전구체로서의 아제티디늄 염, 이의 선택적 제조방법 및 fp-cit 의 합성
SG10201907363YA (en) Methods Of Chemical Synthesis Of Diaminophenothiazinium Compounds Including Methylthioninium Chloride (Mtc)
EA201300792A1 (ru) Химические соединения
MX338556B (es) Metodos para aislar acidos 4-cloro-2-fluoro-3-fenilboronicos sustituidos.
EP3290403A3 (en) Methods of producing molindone and its salts
MX2013004881A (es) Proceso para la preparacion de n-(bencil)ciclopropanaminas sustituidas mediante hidrogenacion de iminas.
NZ598129A (en) Process for the preparation of cathepsin s inhibitors
MX365587B (es) Metodo para preparar derivados de feniloximetil-nitro-imidazol y uso del mismo.

Legal Events

Date Code Title Description
FG Grant or registration